Journal of Dental Research, Vol 80, 351-355, Copyright © 2001 by International & American Associations for Dental Research Online Journals

ARTICLES

Interferon-gamma down-regulates gene expression of cathepsin K in osteoclasts and inhibits osteoclast formation

S. Kamolmatyakul, W. Chen and Y. P. Li
Department of Cytokine Biology, Forsyth Institute & Harvard School of Dental Medicine, Boston, MA 02135, USA.

The cytokine, IFN-gamma, has been shown in vitro to inhibit bone resorption, but the mechanisms responsible for this inhibition have not been clearly defined. Cathepsin K is a major protease responsible for bone resorption. IFN-gamma may inhibit bone resorption through down-regulation of osteoclast genes, including cathepsin K. To test the hypothesis, we investigated the effect of IFN-gamma on cathepsin K expression in the MOCP-5 and wild-type mouse bone marrow co-culture systems by Northern blot as well as osteoclast formation at different stages of differentiation. The results show that IFN-gamma down-regulates mRNA levels of cathepsin K in a time- and dose-dependent manner. Consequently, cathepsin K protein production is also reduced by IFN-gamma. Moreover, our results indicate that IFN-gamma inhibits osteoclast formation only early in osteoclast differentiation. IL-6 and TNFalpha did not significantly affect cathepsin K gene expression in osteoclasts. However, IL-1alpha stimulated gene expression. In conclusion, our data suggest that the actions of IFN-gamma on osteoclastic bone resorption may be mediated by its effects on both osteoclast formation at an early stage and osteoclast gene expression in mature osteoclasts.

This article has been cited by other articles:

				S. Ferrari-Lacraz and S. Ferrari Is IFN-{gamma} Involved in Bone Loss or Protection? Nothing Is Simple With Cytokines IBMS BoneKEy, February 1, 2007; 4(2): 83 - 87. [Full Text] [PDF]

				S. Kamolmatyakul, W. Chen, S. Yang, Y. Abe, R. Moroi, A.M. Ashique, and Y.-P. Li IL-1{alpha} Stimulates Cathepsin K Expression in Osteoclasts via the Tyrosine Kinase-NF-{kappa}B Pathway J. Dent. Res., October 1, 2004; 83(10): 791 - 796. [Abstract] [Full Text] [PDF]

				S. Cenci, G. Toraldo, M. N. Weitzmann, C. Roggia, Y. Gao, W. P. Qian, O. Sierra, and R. Pacifici Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-{gamma}-induced class II transactivator PNAS, September 2, 2003; 100(18): 10405 - 10410. [Abstract] [Full Text] [PDF]

				J. R. Mead, T. R. Hughes, S. A. Irvine, N. N. Singh, and D. P. Ramji Interferon-gamma Stimulates the Expression of the Inducible cAMP Early Repressor in Macrophages through the Activation of Casein Kinase 2. A POTENTIALLY NOVEL PATHWAY FOR INTERFERON-gamma -MEDIATED INHIBITION OF GENE TRANSCRIPTION J. Biol. Chem., May 9, 2003; 278(20): 17741 - 17751. [Abstract] [Full Text] [PDF]

				D.P. Dickinson CYSTEINE PEPTIDASES OF MAMMALS: THEIR BIOLOGICAL ROLES AND POTENTIAL EFFECTS IN THE ORAL CAVITY AND OTHER TISSUES IN HEALTH AND DISEASE Crit. Rev. Oral. Biol. Med., May 1, 2002; 13(3): 238 - 275. [Abstract] [Full Text]

				H Bull, P G Murray, D Thomas, A M Fraser, and P N Nelson Acid phosphatases Mol. Pathol., April 1, 2002; 55(2): 65 - 72. [Abstract] [Full Text] [PDF]